These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6247869

  • 1. Plasma 11-deoxycortisol, androstenedione, testosterone and ACTH in comparison with the urinary excretion of tetrahydro-11-deoxycortisol as indices of the pituitary-adrenal response to oral metyrapone.
    de Lange WE, Sluiter WJ, Pratt JJ, Doorenbos H.
    Acta Endocrinol (Copenh); 1980 Apr; 93(4):488-94. PubMed ID: 6247869
    [Abstract] [Full Text] [Related]

  • 2. The discrepancy between plasma 11-deoxycortisol and ACTH concentrations in a single dose metyrapone test in normal men.
    Matsuki M, Nishida S, Horino M, Tenku A, Oyama H.
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):62-5. PubMed ID: 6289591
    [Abstract] [Full Text] [Related]

  • 3. Improved single-dose metyrapone test.
    Dickstein G, Barzilai D.
    Isr J Med Sci; 1980 May; 16(5):365-9. PubMed ID: 6249771
    [Abstract] [Full Text] [Related]

  • 4. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion.
    Masi AT, Josipović DB, Jefferson WE.
    Semin Arthritis Rheum; 1984 Aug; 14(1):1-23. PubMed ID: 6091273
    [Abstract] [Full Text] [Related]

  • 5. [The discrepancy between ACTH and 11-deoxycortisol levels in a single dose metyrapone test].
    Matsuki M.
    Nihon Naibunpi Gakkai Zasshi; 1983 Feb 20; 59(2):122-30. PubMed ID: 6303868
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the three hour metyrapone test in adults.
    Best JD, Alford FP, Donald RA.
    Clin Endocrinol (Oxf); 1980 Jul 20; 13(1):69-76. PubMed ID: 6254698
    [Abstract] [Full Text] [Related]

  • 7. [Plasma 11-deoxycortisol response to single dose metyrapone in prostatic cancer patients (author's transl)].
    Ohashi T, Morioka M, Akaeda T, Mitsuhata N, Takeda K, Ohmori H, Saito T, Takami T, Kanbegawa A.
    Nihon Naibunpi Gakkai Zasshi; 1981 Jul 20; 57(7):983-96. PubMed ID: 6269918
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic-pituitary-adrenal function in extrinsic asthma.
    Morrish DW, Sproule BJ, Aaron TH, Outhet D, Crockford PM.
    Chest; 1979 Feb 20; 75(2):161-6. PubMed ID: 217570
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH.
    Nelson JC, Tindall DJ.
    Am J Med Sci; 1978 Feb 20; 275(2):165-72. PubMed ID: 208417
    [Abstract] [Full Text] [Related]

  • 10. Single-dose metyrapone test at 06.00 h: an accurate method for assessment of pituitary-adrenal reserve.
    Dickstein G, Lahav M, Orr ZS.
    Acta Endocrinol (Copenh); 1986 May 20; 112(1):28-34. PubMed ID: 3716755
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins.
    Thorén M, Stenfors C, Apéria B, Mathé AA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 May 20; 14(3):319-26. PubMed ID: 2359842
    [Abstract] [Full Text] [Related]

  • 12. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
    Courtney CH, McAllister AS, McCance DR, Hadden DR, Leslie H, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 2000 Sep 20; 53(3):309-12. PubMed ID: 10971447
    [Abstract] [Full Text] [Related]

  • 13. Modification of adrenal function by the anti-serotonin agent cyproheptadine.
    Plonk J, Feldman J.
    J Clin Endocrinol Metab; 1976 Feb 20; 42(2):291-5. PubMed ID: 177441
    [Abstract] [Full Text] [Related]

  • 14. Metyrapone test with adrenocorticotrophic levels. Separating primary from secondary adrenal insufficiency.
    Dolman LI, Nolan G, Jubiz W.
    JAMA; 1979 Mar 23; 241(12):1251-3. PubMed ID: 216821
    [Abstract] [Full Text] [Related]

  • 15. [Circadian variations of 17-hydroxycorticosteroids and of tetrahydro-11-deoxycortisol in the healthy man: effect of the continuous administration of metyrapone (SU 4885)].
    Touitou Y, Bogdan A, Limal JM, Reinberg A.
    C R Acad Hebd Seances Acad Sci D; 1975 Sep 29; 281(13):913-5. PubMed ID: 811399
    [Abstract] [Full Text] [Related]

  • 16. The metyrapone test in pituitary dwarfs--the determination of serum cortisol and 11-deoxycortisol by high-performance liquid chromatography.
    Ginalska-Malinowska M, Małunowicz E, Romer TE, Filipek M.
    Endokrynol Pol; 1987 Sep 29; 38(1):21-7. PubMed ID: 2828014
    [No Abstract] [Full Text] [Related]

  • 17. Hyperprolactinaemia is associated with a higher prevalence of pituitary-adrenal dysfunction in non-functioning pituitary macroadenoma.
    Tjeerdsma G, Sluiter WJ, Hew JM, Molenaar WM, de Lange WE, Dullaart RP.
    Eur J Endocrinol; 1996 Sep 29; 135(3):299-308. PubMed ID: 8890720
    [Abstract] [Full Text] [Related]

  • 18. [Clinical significance of urinary tetrahydro-11-deoxycortisol analysis in endocrine tests of the adrenal cortex].
    Sagara Y, Okatani Y.
    Nihon Rinsho; 1989 Dec 29; 48 Suppl():1203-5. PubMed ID: 2560066
    [No Abstract] [Full Text] [Related]

  • 19. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism.
    Soule S, Van Zyl Smit C, Parolis G, Attenborough S, Peter D, Kinvig S, Kinvig T, Coetzer E.
    Clin Endocrinol (Oxf); 2000 Aug 29; 53(2):221-7. PubMed ID: 10931104
    [Abstract] [Full Text] [Related]

  • 20. Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients.
    Bonnet-Serrano F, Poirier J, Vaczlavik A, Laguillier-Morizot C, Blanchet B, Baron S, Guignat L, Bessiene L, Bricaire L, Groussin L, Assié G, Guibourdenche J, Bertherat J.
    Eur J Endocrinol; 2022 Aug 01; 187(2):315-322. PubMed ID: 35699971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.